Document is current
Any future updates will be listed below
-
Authors
Emani, Prashant S.
Warrell, Jonathan
Anticevic, Alan
Bekiranov, Stefan
Gandal, Michael https://orcid.org/0000-0001-5800-5128
McConnell, Michael J.
Sapiro, Guillermo
Aspuru-Guzik, Alán https://orcid.org/0000-0002-8277-4434
Baker, Justin T.
Bastiani, Matteo
Murray, John D.
Sotiropoulos, Stamatios N.
Taylor, Jacob
Senthil, Geetha
Lehner, Thomas https://orcid.org/0000-0002-1889-1214
Gerstein, Mark B. https://orcid.org/0000-0002-9746-3719
Harrow, Aram W. https://orcid.org/0000-0003-3220-7682
- License Information
-
More Information
Article History
First Online: 4 January 2021
Competing interests
: A.A. serves as a member of the Scientific Advisory Board of, consults for, has received grants from, and holds equity in BlackThorn Therapeutics. G. Sapiro consulted for Apple, Volvo, Restore3D and SIS, and has received speaking fees from Johnson & Johnson. J.T.B. has received consulting fees from BlackThorn Therapeutics, Niraxx Therapeutics, Verily Life Sciences, AbleTo Inc. and Pear Therapeutics, and has received consulting fees and equity from Mindstrong Inc. J.D.M. consults for, has received grants from, and holds equity in BlackThorn Therapeutics. A.W.H. has recently joined the Scientific Advisory Board of Zapata Computing, from which he expects income and equity.
